Shareholders of SpringWorks Therapeutics, Inc. ( NASDAQ:SWTX ) will be pleased this week, given that the stock price is...
SpringWorks Therapeutics Inc (SWTX) reports a 23% revenue increase and anticipates FDA approval for a new treatment, despite short-term challenges.